This 2-year fellowship provides an opportunity to develop an understanding of the functional areas of Medical Communications and Field Medical. Fellows will be afforded the opportunity to build a strong foundation from their first-year experiences in medical communications that they can leverage as they transition into a field based role during the second year of their fellowship. Throughout the course of this fellowship, individuals will not only acquire disease state knowledge, but also master clinical data regarding Bristol-Myers Squibb and competitor oncology products. Fellows will collaborate extensively with a cross-functional matrix (e.g. Legal/Regulatory, Marketing, Medical, and R&D) through leading fellow-driven projects with demonstrable business impact.
Function as a medical communications specialist to enable the healthcare community to advance the science, accelerate access, shape medical practice, and drive appropriate adoption of BMS medicines
Act as a primary point of contact and strategic partner to ensure publications and scientific content meet the local needs & educational gaps
Collaborate closely with the MI contact center in responding to unsolicited requests from health care providers, payers, and patients
Collect market-level insights for bidirectional knowledge sharing & create and deliver content focused on education to enable access within market
Frequent field ride opportunities with MSLs to gain experience in the engagement of oncology thought leaders and other key members of the oncology healthcare team
Play a critical role in the collection and analysis of insights, field account planning, and tumor specific training to gain alignment and understanding of the therapeutic landscape
Work directly on headquarter based field medical projects and attend key Bristol-Myers Squibb meetings (i.e. National Oncology Meetings, Medical Congresses, Continuing Medical Education, Medical Matrix collaboration and MSL training)
Participate in weekly virtual Field Medical meetings (regional calls, journal clubs, and national meetings)
Second-Year Fellow: Thomas A. Nichols, PharmD
Ohio Northern University Raabe College of Pharmacy
First-Year Fellow: Jordan D. Geissinger, PharmD
University of Houston College of Pharmacy
Please consider attending Fellowship Information and Network Day here at Rutgers Ernest Mario School of Pharmacy on November 22nd from 3:30 PM – 8:00 PM so we can visit with you about your interests. For additional information please visit our website: http://pharmafellows.rutgers.edu/applicants/fid.php.
We do not pre-schedule interviews for Midyear, so please do not request an interview via this website. Your emails will not be reviewed.
We will be scheduling interviews starting at 10 AM on December 7th. Prior to scheduling an interview you will need to view the Fellowship information video
Rutgers, The State University of New Jersey, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, gender identity or expression, disability, age, or any other category covered by law in its admission, programs, activities, or employment matters. The following people have been designated to handle inquiries regarding the nondiscrimination policies: Judy Ryan, Universitywide Title IX Coordinator, Office of Enterprise Risk Management, Ethics, and Compliance (732-235-5304, email@example.com); and Lisa Grosskreutz, Director, Office of Employment Equity, University Human Resources (848-932-3980, firstname.lastname@example.org). For further information on the notice of nondiscrimination, you may contact the U.S. Department of Education, Office for Civil Rights, at 646-428-3900 or OCR.NewYork@ed.gov.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.